{
    "question_id": "1",
    "question": "What is the long-term prognosis for primary acute angle-closure glaucoma in the affected eye?",
    "context": "-----Entities(KG)-----\n\n```json\n[{\"id\": 1, \"entity\": \"急性原发性闭角型青光眼\", \"type\": \"疾病\", \"description\": \"急性原发性闭角型青光眼是在发作期由于高眼压导致眼球组织的缺血再灌注损伤，最终导致不可逆转的视力损伤。<SEP>急性原发性闭角型青光眼是本指南讨论的主要疾病。\"}, {\"id\": 2, \"entity\": \"急性闭角型青光眼\", \"type\": \"疾病\", \"description\": \"Acute angle-closure glaucoma is a rare type of glaucoma that can manifest acutely, with some patients presenting with this condition at the onset of the disease. It is classified as a subtype of primary angle-closure glaucoma, characterized by a sudden increase in intraocular pressure. This condition represents a specific type of angle-closure glaucoma, which encompasses several clinical stages that define its progression and impact on patients. The unique characteristics of acute angle-closure glaucoma highlight its distinctiveness within the realm of PACG and outline its significant effects on those affected.<SEP>急性闭角型青光眼是可能由散瞳检查诱发的疾病。<SEP>急性闭角型青光眼是一种急性眼部疾病，需与病毒性角膜内皮炎进行鉴别。\"}, {\"id\": 3, \"entity\": \"视力损伤\", \"type\": \"临床结局\", \"description\": \"Vision impairment is a multifaceted condition that can result from various medical issues and has significant implications for patient health. It may arise after an acute primary angle-closure glaucoma attack, leading to severe outcomes. Diabetic retinopathy (DR), particularly in individuals with type 2 diabetes mellitus, is another common cause of vision loss, marking a critical manifestation of the disease. Additionally, vision impairment is a notable consequence of recurrent optic neuritis associated with neuromyelitis optica spectrum disorder (NMOSD). Moreover, vision impairment can stem from untreated eye diseases, potentially resulting in blindness. Conditions such as X-linked retinoschisis (XLRS) also contribute to vision impairment, adversely affecting the quality of life for patients. Furthermore, individuals with myopia may experience vision loss as a clinical manifestation. This comprehensive overview underscores the diverse origins of vision impairment and its serious repercussions in various health contexts.<SEP>视力损伤表现为轻中重度到极重度。<SEP>视力损伤程度与眼内异物伤机制、异物种类及并发症等因素有关。\"}, {\"id\": 4, \"entity\": \"眼球组织的缺血再灌注损伤\", \"type\": \"临床表现\", \"description\": \"眼球组织的缺血再灌注损伤是急性原发性闭角型青光眼发作过程中发生的损伤，导致视力不可逆转的损害。\"}, {\"id\": 5, \"entity\": \"慢性闭角型青光眼\", \"type\": \"疾病\", \"description\": \"慢性闭角型青光眼是原发性闭角型青光眼的另一种类型，症状较为缓慢进展。<SEP>慢性闭角型青光眼是闭角型青光眼的一种延续情况，涉及眼压变动和视神经受损。\"}, {\"id\": 6, \"entity\": \"绝对期\", \"type\": \"临床结局\", \"description\": \"绝对期是在原发性闭角型青光眼的一种进展状态，表明疾病处于晚期。<SEP>绝对期是慢性闭角型青光眼的最终阶段，视神经将不可逆转受损。\"}, {\"id\": 7, \"entity\": \"社区人群原发性闭角型青光眼\", \"type\": \"疾病\", \"description\": \"社区人群原发性闭角型青光眼是青光眼筛查中的一个特定人群。\"}, {\"id\": 8, \"entity\": \"原发性闭角型青光眼\", \"type\": \"疾病\", \"description\": \"Primary angle-closure glaucoma (PACG) is a significant health issue in China and is recognized as the leading cause of irreversible blindness globally. This condition arises from primary angle closure and is characterized by acute or chronic increases in intraocular pressure, which can lead to alterations in the optic disc and visual field damage. Approximately 25% of patients affected by PACG may experience bilateral blindness.\\n\\nPACG is a central focus within clinical guidelines in ophthalmology, emphasizing its severity and the urgent need for awareness, diagnosis, and intervention. The guidelines outline different types of angle narrowing associated with PACG, along with the indications and protocols for surgical treatment. Consequently, PACG is highlighted as a critical concern, requiring thorough understanding and management to reduce its impact on vision and overall health.\"}, {\"id\": 9, \"entity\": \"急性青光眼\", \"type\": \"危险因素\", \"description\": \"急性青光眼与角膜内皮细胞健康相关联，可能影响手术指征。\"}, {\"id\": 10, \"entity\": \"视神经损伤\", \"type\": \"危险因素\", \"description\": \"Optic nerve damage is a significant clinical concern primarily associated with glaucoma, particularly in patients suffering from advanced stages of primary angle-closure glaucoma. This condition often results from severe increases in ocular pressure, leading to both structural and functional impairments of the optic nerve. The risk of optic nerve damage is heightened by extended puncture needle lengths in certain medical procedures, particularly when these lengths exceed 31mm, though such incidents are rare. Additionally, optic nerve damage may occur due to mechanical ocular trauma, which is a major cause of non-light perception in affected eyes.\\n\\nThis condition can lead to a decline in vision, necessitating specific treatment strategies, especially tailored according to the injury's severity. Moreover, optic nerve damage has been linked to the elongation of the ocular axis, which is particularly relevant among glaucoma patients. The critical need for early intervention and proactive treatment strategies emphasizes the importance of monitoring and addressing optic nerve health to mitigate progression and improve patient outcomes. Overall, optic nerve damage remains a key focus in medical guidelines due to its significant impact on visual function recovery and the necessity of proper management in relevant scenarios.\"}, {\"id\": 11, \"entity\": \"角型青光眼\", \"type\": \"疾病\", \"description\": \"角型青光眼是本指南讨论的主要疾病，患者在散瞳前需进行相关检查。\"}, {\"id\": 12, \"entity\": \"慢性期\", \"type\": \"临床表现\", \"description\": \"The chronic phase is a stage in the progression of various medical conditions, particularly in the context of acute angle-closure glaucoma and central retinal artery occlusion. It is defined as a period in which the disease has persisted for more than 28 days, during which symptoms remain ongoing. In addition to being a phase of acute angle-closure glaucoma characterized by continuous symptoms, the chronic phase also serves as a condition for patients to receive treatment for several other related disorders. Furthermore, in cases of central retinal artery occlusion, the chronic phase may present with additional signs, such as pallor of the optic disc. Overall, the chronic phase represents a significant period in the management and understanding of these conditions.<SEP>慢性期是LHON的另一阶段，可能伴随视力持续下降的表现。\"}, {\"id\": 13, \"entity\": \"慢性前房角关闭\", \"type\": \"临床表现\", \"description\": \"慢性前房角关闭是原发性闭角型青光眼的一种表现形式。\"}, {\"id\": 14, \"entity\": \"术后瘢痕\", \"type\": \"临床表现\", \"description\": \"术后瘢痕是急性原发性闭角型青光眼治疗后可能出现的临床表现。\"}, {\"id\": 15, \"entity\": \"视野损害\", \"type\": \"临床表现\", \"description\": \"视野损害是原发性闭角型青光眼的临床表现之一。\"}, {\"id\": 16, \"entity\": \"放射性视网膜病变\", \"type\": \"临床表现\", \"description\": \"放射性视网膜病变是放射治疗后影响患者视力的主要原因之一。<SEP>放射性视网膜病变是敷贴放射治疗后的主要并发症之一。<SEP>放射性视网膜病变是眼眶放射治疗所可能引发的晚期放射损伤。\"}, {\"id\": 17, \"entity\": \"视力预后\", \"type\": \"临床结局\", \"description\": \"Vision prognosis serves as a crucial indicator of treatment effectiveness for Diabetic Macular Edema (DME), significantly influenced by the choice of medications utilized. The incorporation of corticosteroids has been proposed to enhance vision prognosis for patients dealing with this condition. It acts as a primary clinical outcome, where improvements in vision prognosis can be achieved through innovative treatment methods that ultimately impact the patient's quality of life and are closely tied to effective disease management.\\n\\nMoreover, the rational use of immunosuppressants and biological agents has been shown to markedly enhance vision prognosis. Specifically, \\\"vision prognosis\\\" refers to the degree of vision improvement following treatment, which is critically influenced by the location and extent of lesions; larger lesions generally correlate with a poorer prognosis. Therefore, effectively managing both the treatment strategy and the characteristics of the lesions is vital to achieving optimal patient outcomes.\\n\\nFurthermore, early treatment and timely referrals have been recognized as significant factors in improving vision prognosis. Overall, patients tend to have a good vision prognosis, indicating that with appropriate interventions, many individuals can achieve favorable outcomes in their visual health.\"}, {\"id\": 18, \"entity\": \"临床前期\", \"type\": \"临床表现\", \"description\": \"临床前期指的是原发性急性闭角型青光眼的初期阶段。<SEP>临床前期是急性闭角型青光眼的一个早期阶段，尚未出现视神经损伤。\"}, {\"id\": 19, \"entity\": \"视神经改变\", \"type\": \"临床表现\", \"description\": \"视神经改变是青光眼患者需要监测的临床表现之一。\"}]\n```\n\n-----Relationships(KG)-----\n\n```json\n[{\"id\": 1, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"青光眼\", \"description\": \"原发性闭角型青光眼是青光眼的一种主要类型。\"}, {\"id\": 2, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"视力损伤\", \"description\": \"视力损伤是急性原发性闭角型青光眼的严重并发症。\"}, {\"id\": 3, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"糖皮质激素\", \"description\": \"糖皮质激素帮助减轻急性原发性闭角型青光眼的炎性反应。\"}, {\"id\": 4, \"entity1\": \"慢性闭角型青光眼\", \"entity2\": \"绝对期\", \"description\": \"绝对期为慢性闭角型青光眼的终末阶段，视神经损伤无法恢复。\"}, {\"id\": 5, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"眼压\", \"description\": \"高眼压是原发性闭角型青光眼的一种临床表现，需通过手术和药物控制。\"}, {\"id\": 6, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"视神经损伤\", \"description\": \"视神经损伤是原发性闭角型青光眼未及时治疗后的表现。\"}, {\"id\": 7, \"entity1\": \"眼压\", \"entity2\": \"角型青光眼\", \"description\": \"在散瞳前，角型青光眼患者可能会有眼压升高的临床表现。\"}, {\"id\": 8, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"绝对期\", \"description\": \"绝对期是原发性闭角型青光眼的发展阶段之一，表明病情已严重。\"}, {\"id\": 9, \"entity1\": \"慢性前房角关闭\", \"entity2\": \"眼压\", \"description\": \"慢性前房角关闭可能导致眼压逐渐升高。\"}, {\"id\": 10, \"entity1\": \"急性闭角型青光眼\", \"entity2\": \"慢性期\", \"description\": \"慢性期标志着急性闭角型青光眼的长期病程进展。\"}, {\"id\": 11, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"眼压升高\", \"description\": \"眼压升高是原发性闭角型青光眼的临床表现之一。\"}, {\"id\": 12, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"术后瘢痕\", \"description\": \"术后瘢痕是急性原发性闭角型青光眼治疗后可能出现的临床表现。\"}, {\"id\": 13, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"眼外伤\", \"description\": \"眼外伤是导致急性原发性闭角型青光眼禁忌证之一的眼部疾病。\"}, {\"id\": 14, \"entity1\": \"放射性视网膜病变\", \"entity2\": \"视力预后\", \"description\": \"放射性视网膜病变对患者视力产生影响，需长期监测。\"}, {\"id\": 15, \"entity1\": \"急性闭角型青光眼\", \"entity2\": \"病毒性角膜内皮炎\", \"description\": \"急性闭角型青光眼的症状需与病毒性角膜内皮炎进行鉴别。\"}, {\"id\": 16, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"视野损害\", \"description\": \"视野损害是原发性闭角型青光眼的重要临床表现。\"}, {\"id\": 17, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"房水\", \"description\": \"房水的流动和压力变化与原发性闭角型青光眼的发病机制相关。\"}, {\"id\": 18, \"entity1\": \"临床前期\", \"entity2\": \"急性闭角型青光眼\", \"description\": \"临床前期与急性闭角型青光眼相对应，未出现视神经损伤。<SEP>临床前期是急性闭角型青光眼的早期阶段。\"}, {\"id\": 19, \"entity1\": \"急性闭角型青光眼\", \"entity2\": \"视神经改变\", \"description\": \"急性闭角型青光眼患者可能会出现视神经的改变。\"}, {\"id\": 20, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"微创青光眼手术\", \"description\": \"微创青光眼手术被应用于原发性闭角型青光眼的治疗。<SEP>微创青光眼手术被用于治疗原发性闭角型青光眼。<SEP>微创青光眼手术逐渐成为原发性闭角型青光眼的新治疗选择。\"}, {\"id\": 21, \"entity1\": \"慢性闭角型青光眼\", \"entity2\": \"眼压升高\", \"description\": \"慢性闭角型青光眼通常伴随眼压升高。\"}, {\"id\": 22, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"小梁切除术\", \"description\": \"小梁切除术被认为是治疗原发性闭角型青光眼的传统方法。\"}, {\"id\": 23, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"虹膜\", \"description\": \"虹膜在PACG的发病机制中发挥重要作用，是发生和发展的始动因素。\"}, {\"id\": 24, \"entity1\": \"裂隙灯显微镜\", \"entity2\": \"角型青光眼\", \"description\": \"裂隙灯显微镜是检查角型青光眼患者前房深度的方法，重要于散瞳前。\"}, {\"id\": 25, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"房角分离术\", \"description\": \"房角分离术被推荐作为治疗原发性闭角型青光眼的手段之一。\"}, {\"id\": 26, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"急性闭角型青光眼\", \"description\": \"急性闭角型青光眼是原发性闭角型青光眼的一个子类型，具有不同的临床表现。\"}, {\"id\": 27, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"视野损伤\", \"description\": \"视野损伤是原发性闭角型青光眼患者的常见临床表现。\"}, {\"id\": 28, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"眼压检查\", \"description\": \"眼压检查也是原发性闭角型青光眼的重要诊断方法。\"}, {\"id\": 29, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"房角狭窄\", \"description\": \"房角狭窄是原发性闭角型青光眼的一个主要临床表现。\"}, {\"id\": 30, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"周边虹膜切除\", \"description\": \"周边虹膜切除是治疗原发性闭角型青光眼的一种手术方法。\"}, {\"id\": 31, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"围手术期用药\", \"description\": \"围手术期用药是原发性闭角型青光眼手术治疗中不可或缺的一部分。\"}, {\"id\": 32, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"眼压高\", \"description\": \"眼压高是原发性闭角型青光眼可能出现的一个症状。\"}, {\"id\": 33, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"房角分离/房角成形术\", \"description\": \"房角分离/房角成形术作为青光眼的治疗手段，有助于改善原发性闭角型青光眼患者的症状。\"}, {\"id\": 34, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"基因\", \"description\": \"基因位点与PACG的相关性被研究发现。\"}, {\"id\": 35, \"entity1\": \"小梁切除术\", \"entity2\": \"急性原发性闭角型青光眼\", \"description\": \"小梁切除术是治疗无法控制眼压的急性原发性闭角型青光眼的方法。\"}, {\"id\": 36, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"滤过性手术\", \"description\": \"滤过性手术是另一种治疗原发性闭角型青光眼的方法。\"}, {\"id\": 37, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"瞳孔散大\", \"description\": \"瞳孔散大是导致PACG发作的危险因素。\"}, {\"id\": 38, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"高眼压\", \"description\": \"高眼压是急性原发性闭角型青光眼的发作表现，导致眼球组织损伤。\"}, {\"id\": 39, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"周边虹膜切除术\", \"description\": \"周边虹膜切除术是治疗原发性闭角型青光眼的手术方法之一。\"}, {\"id\": 40, \"entity1\": \"前房角关闭\", \"entity2\": \"原发性闭角型青光眼\", \"description\": \"前房角关闭是原发性闭角型青光眼的主要临床表现。\"}, {\"id\": 41, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"慢性闭角型青光眼\", \"description\": \"慢性闭角型青光眼也是原发性闭角型青光眼的子类型，但进展较慢。\"}, {\"id\": 42, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"透明晶状体摘除术\", \"description\": \"透明晶状体摘除术被探讨为对原发性闭角型青光眼的潜在一线治疗方式。<SEP>透明晶状体摘除术被推荐为PACG的首选治疗。\"}, {\"id\": 43, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"视盘改变\", \"description\": \"视盘改变是由原发性闭角型青光眼导致的临床表现之一。\"}, {\"id\": 44, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"暗室试验\", \"description\": \"暗室试验用于帮助确认原发性闭角型青光眼的诊断。\"}, {\"id\": 45, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"暗室俯卧试验\", \"description\": \"暗室俯卧试验也被用作原发性闭角型青光眼的诊断工具。\"}, {\"id\": 46, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"晶状体青光眼斑\", \"description\": \"晶状体青光眼斑与原发性闭角型青光眼相关。\"}, {\"id\": 47, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"局部和全身降眼压药物\", \"description\": \"局部和全身降眼压药物用于原发性闭角型青光眼的急性治疗。\"}, {\"id\": 48, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"微脉冲经巩膜激光治疗\", \"description\": \"微脉冲经巩膜激光治疗用于治疗原发性闭角型青光眼。\"}, {\"id\": 49, \"entity1\": \"单纯性瞳孔阻滞型\", \"entity2\": \"原发性闭角型青光眼\", \"description\": \"单纯性瞳孔阻滞型是原发性闭角型青光眼的一种分类。\"}, {\"id\": 50, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"虹膜高褶型\", \"description\": \"虹膜高褶型是原发性闭角型青光眼的一种分类。\"}, {\"id\": 51, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"睫状体前位型\", \"description\": \"睫状体前位型是原发性闭角型青光眼的一种分类。\"}, {\"id\": 52, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"晶状体位置异常型\", \"description\": \"晶状体位置异常型是原发性闭角型青光眼的一种分类。\"}, {\"id\": 53, \"entity1\": \"原发性闭角型青光眼\", \"entity2\": \"脉络膜膨隆型\", \"description\": \"脉络膜膨隆型是原发性闭角型青光眼的一种分类。\"}, {\"id\": 54, \"entity1\": \"并发性白内障\", \"entity2\": \"急性原发性闭角型青光眼\", \"description\": \"并发性白内障是急性原发性闭角型青光眼的一个适应证。\"}, {\"id\": 55, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"降眼压药物治疗\", \"description\": \"降眼压药物治疗是急性原发性闭角型青光眼的首选处理方式。\"}, {\"id\": 56, \"entity1\": \"原发性开角型青光眼\", \"entity2\": \"社区人群原发性闭角型青光眼\", \"description\": \"这两种青光眼类型的联合筛查能够提升筛查效果。\"}, {\"id\": 57, \"entity1\": \"前房穿刺术\", \"entity2\": \"急性闭角型青光眼\", \"description\": \"前房穿刺术用于降低急性闭角型青光眼患者的眼压。\"}, {\"id\": 58, \"entity1\": \"地塞米松\", \"entity2\": \"急性原发性闭角型青光眼\", \"description\": \"地塞米松用于帮助控制急性原发性闭角型青光眼患者的眼压。\"}, {\"id\": 59, \"entity1\": \"急性闭角型青光眼\", \"entity2\": \"房角狭窄\", \"description\": \"急性闭角型青光眼的发生与房角狭窄有密切关系。\"}, {\"id\": 60, \"entity1\": \"病史\", \"entity2\": \"角型青光眼\", \"description\": \"询问病史是评估角型青光眼患者的一部分。\"}, {\"id\": 61, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"房角镜检查\", \"description\": \"房角镜检查用于评估急性原发性闭角型青光眼患者的房角粘连，决定治疗策略。\"}, {\"id\": 62, \"entity1\": \"急性闭角型青光眼\", \"entity2\": \"散瞳检查\", \"description\": \"散瞳检查可能诱发急性闭角型青光眼的发作。\"}, {\"id\": 63, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"泼尼松龙\", \"description\": \"泼尼松龙用于帮助控制急性原发性闭角型青光眼患者的眼压。\"}, {\"id\": 64, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"角膜异常\", \"description\": \"角膜异常是在急性原发性闭角型青光眼的禁忌证中提及的眼部疾病。\"}, {\"id\": 65, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"虹膜粘连\", \"description\": \"虹膜粘连是急性原发性闭角型青光眼治疗后可能的临床表现。\"}, {\"id\": 66, \"entity1\": \"急性原发性闭角型青光眼\", \"entity2\": \"眼球组织的缺血再灌注损伤\", \"description\": \"眼球组织的缺血再灌注损伤是急性原发性闭角型青光眼发作期间的主要临床表现。\"}, {\"id\": 67, \"entity1\": \"急性发作期\", \"entity2\": \"急性闭角型青光眼\", \"description\": \"急性发作期是病情进展的重要标志，通常伴随严重症状。\"}, {\"id\": 68, \"entity1\": \"急性闭角型青光眼\", \"entity2\": \"睫状体脱离\", \"description\": \"急性闭角型青光眼的患者可能伴随睫状体脱离的临床表现。\"}, {\"id\": 69, \"entity1\": \"急性闭角型青光眼\", \"entity2\": \"间歇期\", \"description\": \"间歇期表现为急性闭角型青光眼的暂时稳态，症状可能减轻。\"}, {\"id\": 70, \"entity1\": \"先兆期\", \"entity2\": \"急性闭角型青光眼\", \"description\": \"先兆期反映了急性闭角型青光眼的一个阶段，症状开始显现。<SEP>先兆期常接踵于临床前期，是急性闭角型青光眼的发展阶段。\"}, {\"id\": 71, \"entity1\": \"急性闭角型青光眼\", \"entity2\": \"狭小房角\", \"description\": \"狭小房角是引发急性闭角型青光眼的重要解剖结构。\"}, {\"id\": 72, \"entity1\": \"标准七视野立体照相方案\", \"entity2\": \"角型青光眼\", \"description\": \"标准七视野立体照相方案用于对复杂病情的角型青光眼患者进行详细检查。\"}, {\"id\": 73, \"entity1\": \"急性青光眼\", \"entity2\": \"角膜内皮\", \"description\": \"急性青光眼会影响角膜内皮细胞的健康，需注意对手术的影响。\"}, {\"id\": 74, \"entity1\": \"测量眼压\", \"entity2\": \"角型青光眼\", \"description\": \"测量眼压是角型青光眼患者进行检查的关键方法。\"}, {\"id\": 75, \"entity1\": \"前房角粘连\", \"entity2\": \"慢性前房角关闭\", \"description\": \"前房角粘连是导致慢性前房角关闭的重要因素。\"}]\n```\n\n-----Document Chunks(DC)-----\n\n```json\n[{\"id\": 1, \"content\": \"Corresponding author: Zhang Xiulan, Email: zhangxl2@mail.sysu.edu.cn\\n\\n[Abstract] Minimally invasive glaucoma surgery (MIGS) has been successfully incorporated in clinical practice in recent years. Increasing evidence shows that MIGS also plays an increasingly important role in the treatment of primary angle-closure glaucoma (PACG). Surgical peripheral iridectomy (SPI) plus goniosynechialysis (GSL) and goniotomy (GT), as a new procedure, has been proven to be safe and effective in the treatment of PACG with no or mild cataracts. However, there is still a lack of uniform standards for indications, surgical procedures, and perioperative medication. Therefore, it is necessary to formulate a detailed and complete expert recommendations on surgical procedures to standardize the application of combined  $\\\\mathrm{SPI} + \\\\mathrm{GSL} + \\\\mathrm{GT}$  in the treatment. Some experts in glaucoma treatment and management in China have discussed the current problems and developing trend in MIGS for PACG and put forward the expert recommendations of standard process, including indications, anaesthetic methods, surgical site, operating procedure and rational administration of drugs in perioperation, in order to standardize the medical process of clinicians using combined  $\\\\mathrm{SPI} + \\\\mathrm{GSL} + \\\\mathrm{GT}$  in PACG treatment and lay a foundation for better evaluation of the efficacy of MIGS.\\n\\n[Key words] Primary angle-closure glaucoma; Minimally invasive glaucoma surgery; Surgical peripheral iridectomy; Goniosynechialysis; Goniotomy; Expert recommendation DOI:10.3760/cma.j.cn115989-20221127-00552\\n\\n青光眼是全球首位不可逆性致盲眼病，其致盲患者中约  $50\\\\%$  是原发性闭角型青光眼（primaryangle-closure glaucoma，PACG）。我国PACG患病率及致盲率均较高，全球约  $50\\\\%$  的PACG病例在我国[1-2]。手术是PACG的一线治疗方法，既往针对合并透明晶状体或没有白内障手术指征的中晚期PACG的首选手术方案是小梁切除术[3-4]，但小梁切除术并发症较多，如创口较大、浅前房、持续性低眼压、角膜内皮失代偿、眼内炎、恶性青光眼以及滤过泡相关并发症等[5]，也存在医师学习曲线长、术后需要长期的精细处理等问题。因此，临床工作中对于一些特殊情况，如年轻、具有恶性青光眼特征的PACG患者，既往通常采用虹膜周边切除术(surgical peripheral iridectomy，SPI)联合术后降眼压药物替代治疗[6-8]。\\n\\n微创青光眼手术（minimally invasive glaucoma surgery, MIGS)近年来在临床上得到广泛开展。SPI联合房角分离（goniosynechialysis, GSL）及房角切开术（goniotomy, GT）（同内路 Schlemm 切开术，ab internotrabeculotomy）作为一种新型的微创青光眼联合术式，通过 SPI 解除瞳孔阻滞，沟通前后房；GSL 分离前粘连的虹膜，重新开放房角；GT 切开病变小梁网组织，增加房水外流从而降低眼压[9]。已有临床研究和临床实践表明其适用于合并透明晶状体或没有白内障手术指征的中晚期 PACG 的治疗[10-13]。由于其手术操作简单、快捷、并发症少，有望替代小梁切除术并成为此类患者的优选手术方式。然而，随着  $\\\\mathrm{SPI} + \\\\mathrm{GSL} + \\\\mathrm{GT}$  手术的广泛开展，其手术操作、围手术期用药仍缺乏统一的规范。因此，制定一个完整详细的手术操作规范，为临床医生的相关实践提供专家指导意见非常有必要。为了规范 SPI 联合 GSL 及 GT 的治疗方法，国内部分青光眼治疗专家共同讨论并对目前相关治疗方法中存在的问题进行分析，提出 SPI 联合 GSL 及 GT 治疗 PACG 专家推荐意见。\", \"file_path\": \"./medical_guide_markdown/周边虹膜切除联合房角分离及房角切开术操作规范专家推荐意见 .md\"}, {\"id\": 2, \"content\": \"# 中国眼内异物伤诊疗专家共识（2021年）\\n\\n中华医学会眼科学分会眼外伤学组通信作者：颜华，天津医科大学总医院眼科 300052，Email：zyyyanhua@tmu.edu.cn\\n\\n【摘要】 眼内异物伤是一种特殊类型的眼外伤，不仅造成眼球机械性损伤，也可因眼内异物存留引起眼部一系列病理改变，严重威胁视功能。近年来随着医学影像学技术进步，眼内异物伤诊断水平明显提高；眼科显微手术技术的进步与普及，尤其玻璃体视网膜手术技术的不断提高，使眼内异物取出的成功率明显上升。为进一步规范眼内异物伤救治的原则和方法，中华医学会眼科学分会眼外伤学组经过认真讨论，达成共识性意见，以供眼科医师在临床工作中参考使用。（中华眼科杂志 202157 ：819-824）\\n\\n【关键词】 眼异物； 诊疗准则（主题）； 多数赞同\\n\\nChinese expert consensus on the diagnosis and treatment of intraocular foreign bodies (2021)\\n\\nChina Ocular Trauma Society\\nCorresponding author: Yan Hua, Department of Ophthalmology, Tianjin Medical University General\\nHospital, Tianjin 300052, China, Email: zyyyanhua@tmu.edu.cn\\n\\n【Abstract】 Intraocular foreign body injury, as a special type of eye trauma, threatens visual function seriously via mechanical damage and a series of pathological changes to the eyeball due to the presence of a foreign body in the eye. Recently, the diagnosis of intraocular foreign body injury has been distinctly improved attributing to the advancement of medical imaging technology. Moreover, the ophthalmic microsurgery technology has been promoted and popularized, especially the technology of vitrectomy, which enhances the success rate of intraocular foreign body removal remarkably. In order to further standardize the principles and strategies for treatment of intraocular foreign body, China Ocular Trauma Society has reached a consensus based on serious discussions, which can be applied to ophthalmologists′ daily clinical work as a reference. (Chin J Ophthalmol, 2021, 57: 819-824)\\n\\n【Key words】 Eye foreign bodies; Practice guidelines as topic; Consensus\\n\\n眼外伤是世界范围内单眼视力损伤或单眼盲的主要原因［1‑4］ 。眼部受到外伤后，异物进入并存留于眼球内称为眼内异物伤。在开放性眼外伤中，眼内异物伤的发生率为 $1 8 \\\\% { \\\\sim } 4 1 \\\\%$ 。临床按异物性质，将眼内异物分为磁性异物和非磁性异物两大类。非磁性异物包括金属异物（铜、锌、铝、镍等）和非金属异物。非金属异物除石块、玻璃、塑料、矿渣、陶瓷外，还包括植物性异物（树枝、竹刺、麦芒、豆类、纸屑等）和动物性异物（睫毛、昆虫肢体、毛发等）。植物性和动物性异物的发生率虽然较低，但其生物学特性多引起剧烈炎性反应［5‑6］ 。眼内异物伤既包括异物进入眼内时所造成的机械性损伤，又涉及异物存留引起的一系列病理改变，如感染性眼内炎、虹膜睫状体炎、铁质沉着症、铜质沉着症等。视力损伤程度与眼内异物伤机制、异物种类、眼内损伤部位、异物所致并发症等诸多因素有关。因此，眼内异物伤治疗应包括眼内异物取出及并发症处理。目前针对我国眼内异物伤的检查、诊断、手术时机把握和手术方式选择尚缺乏统一标准，导致临床医师在诊疗工作中难以把握尺度。为进一步规范临床眼内异物伤的诊疗工作，提高诊疗水平，中华医学会眼科学分会眼外伤学组在总结国内外文献的基础上，经过充分认真讨论，达成共识性意见，以期为临床工作提供指导意见。\", \"file_path\": \"./medical_guide_markdown/中国眼内异物伤诊疗专家共识（2021年）.md\"}, {\"id\": 3, \"content\": \"# 中国原发性闭角型青光眼诊治方案专家共识（2019年）\\n\\n中华医学会眼科学分会青光眼学组通信作者：王宁利，首都医科大学附属北京同仁医院北京同仁眼科中心 北京市眼科研究所 北京市眼科学与视觉科学重点实验室 100730，Email：wningli@vip.163.com\\n\\n【摘要】 原发性闭角型青光眼（PACG）是临床多见疾病，近年的研究取得了新的进展。为此中华医学会眼科学分会青光眼学组以眼科循证医学为基础，对我国PACG的分类体系和诊断方法以及治疗原则达成进一步共识性意见，以供临床医师参考使用。（中华眼科杂志 2019 55：325-328）\\n\\nDOI: 10.3760/cma.j.issn.0412‑4081.2019.05.002\\n\\n原 发 性 闭 角 型 青 光 眼（primary angle closure， ）是由原发性房角关闭所导致的急性或慢性眼压升高，造成视盘改变和视野损伤的组疾病。近年关于PACG的研究取得了新的进展，为此中华医学会眼科学分会青光眼学组以眼科循证医学为基础，经过充分讨论，对我国 的分类体系和诊断方法以及治疗原则达成进一步共识性意见，以供临床医师在对青光眼进行诊断和治疗时参考使用。\\n\\n## 一、关于PACG发病机制及治疗的新认识\\n\\n近年针对PACG的研究取得了新的进展。研究发现PACG的发生和发展与虹膜‑睫状体‑脉络膜组成的葡萄膜病理生理改变相关。虹膜 睫状体脉络膜均由中胚层发育而来，在生理状态下时刻处于动态变化中，使之成为 发作的危险因素。当瞳孔散大时，虹膜膨隆加重，虹膜容积减小［1‑3］ ；睫状肌的舒张和收缩均可造成晶状体厚度和晶状体悬韧带的改变，进而导致前房进一步变浅［4］ ；脉络膜厚度的增加推动虹膜 晶状体隔前移，导致前房和房角变化［5‑6］。因此，虹膜‑睫状体‑脉络膜在的发病机制中发挥重要作用，是 发生和发展的始动因素。\\n\\n遗传学研究结果也证明了葡萄膜与PACG的相关性。CHAT基因与睫状肌、瞳孔括约肌调控相关［7］；ABCC5 基因与中央前房深度相关［8］；EPDR1基因与血管组织细胞的黏附性以及脉络膜膨胀相关［7］ 。以上研究发现的基因位点均与葡萄膜的解剖和病理生理变化密切相关。\\n\\n针对 的治疗，近期国际透明晶状体摘除术 治 疗 PACG（effectiveness of early lens extractionfor the treatment of primary angle‑closure glaucoma，EAGLE）研究组织对5个国家155例原发性房角关闭和263例PACG患者进行多中心、随机对照研究，发现透明晶状体摘除术的综合疗效优于周边虹膜切除术，并推荐其可作为 的首选治疗［9］ 。然而， 研究是在限定人群中进行的，数据是经英国医疗卫生体系评价，不能代表我国的卫生经济学现况。若在我国首选透明晶状体摘除术治疗，仍需有立足于我国医疗实际的高级别循证医学研究证据支持。因此，中华医学会眼科学分会青光眼学组专家认为，EAGLE研究结果尚不符合我国国情，待我国相关临床研究完成提出证据后再行相关讨论［10‑11］ 。\", \"file_path\": \"./medical_guide_markdown/中国原发性闭角型青光眼诊治方案专家共识（2019年）.md\"}]\n```\n\n",
    "mode": "hybrid",
    "only_need_retrieved_context_list": false,
    "only_need_entity_and_relation_str": false,
    "only_need_context": true,
    "only_need_prompt": false,
    "response_type": "Multiple Paragraphs",
    "stream": false,
    "top_k": 10,
    "chunk_top_k": 20,
    "rerank_top_n": 3,
    "max_entity_tokens": 6000,
    "max_relation_tokens": 8000,
    "max_total_tokens": 30000,
    "hl_keywords": [],
    "ll_keywords": [],
    "conversation_history": [],
    "history_turns": 0,
    "ids": null,
    "model_func": null,
    "user_prompt": null,
    "enable_rerank": true
}